Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have cloned a new member of human ankyrin repeat and SOCS box containing protein family (ASB), designed as hASB-8, from a human placental cDNA library and further extended by 5(') and 3(')-RACE. The full-length cDNA was 2545bp in length, with a predicted open reading frame encoding a protein of 288 amino acids, which was 96% identical to mouse
ASB-8
protein. Computer analysis revealed that the deduced amino acid sequence of the human
ASB-8
contained four Ankyrin repeats and one SOCS box. The gene had four exons separated by three introns and was mapped to human chromosome 12q13. Human
ASB-8
mRNA was expressed at the highest level of expression in skeletal muscle and at a varied level of expression in heart, brain, placenta, liver, kidney, and pancreas. The transcript of hASB-8 was not detected in adult normal lung tissue, but found in
lung carcinoma
cell lines SPC-A1, A549, and NCI-H446. Subcellular localization analysis showed that the EGFP-tagged hASB-8 protein was localized at cytoplasm in human hepatocellular carcinoma cell line BEL-7402. We also provided evidence that hASB-8 could interact with Elongin B-C complex in vitro. Furthermore, transfection with the truncated mutant of hASB-8 cDNA lacking SOCS box could suppress cell growth of lung adenocarcinoma SPC-A1 cells in vitro, which suggests that this gene might be related to the development of lung cancer.
...
PMID:Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. 1255 69
ASB-8
is a new member of the human ankyrin repeat and SOCS box containing protein family (ASB). This report deals with the expression of
ASB-8
protein in
lung carcinoma
tissue, as well as its biological effect on the proliferation and growth of lung cancer cell line SPC-A1.
ASB-8
was expressed in pT7-450 expression vector, and an anti-
ASB-8
rabbit polyclonal antibody was prepared. The expression of
ASB-8
protein in
lung carcinoma
tissue was detected using immunohistochemistry. The growth characteristics of the lung adenocarcinoma SPC-A1 cells expressing either exogenous
ASB-8
or
ASB-8
SB (SOCS box-deficient) was studied by both in vitro cell growth curve and in vivo nude mouse tumor formation assay. Immunohistochemical staining detected positive reaction of 96.8% (30/31) showing that
ASB-8
was highly expressed in lung cancer tissues; however, the expression of
ASB-8
was lower, or even no expression in noncancerous lung tissues. Significant growth inhibition was observed in SPC-A1 cell line expressing
ASB-8
SB on day 4 and persisted to day 6, compared with mock transfected cells (P<0.01). No difference in the growth properties was observed between
ASB-8
and mock transfected cells. In vivo study also showed that tumor formation of
ASB-8
SB expressing cells was significantly inhibited as compared with that of the control group (P<0.01). Therefore,
ASB-8
may play an important role in growth and proliferation of lung cancer, possibly as positive regulator.
...
PMID:[Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells]. 1279 16